A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Adjuvant Chemotherapy In Elderly With Colon Cancer Stage III
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MEtronomic TrEatment Option in Advanced bReast cAncer
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab
- Status
- COMPLETED
- Phase
- PHASE3
Multicentric Randomised Trial for Resectable Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Lenvatinib and Capecitabine in Patients With Advanced Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
- Status
- SUSPENDED
- Phase
- PHASE2
Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE3